SCHEMBL13021233

SCHEMBL13021233

CC(C)=CCNc1ncnc2c1c(/C(N)=N\O)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HIF1A Q16665 3/20 0.75
▸ TP53 P04637 3/20 0.75
▸ STAT6 P42226 2/20 0.75
▸ PAX8 Q06710 2/20 0.68
▸ ADK P55263 6/20 0.52
▸ HTT P42858 3/20 0.52
▸ ALDH1A1 P00352 2/20 0.52
▸ NPC1 O15118 1/20 0.52
▸ GALR3 O60755 1/20 0.52
▸ S1PR4 O95977 1/20 0.52
▸ MAPT P10636 1/20 0.52
▸ S1PR1 P21453 1/20 0.52
▸ RAB9A P51151 1/20 0.52
▸ ALOX15 P16050 2/20 0.49
▸ LMNA P02545 1/20 0.49
▸ TSHR P16473 1/20 0.49
▸ RXFP1 Q9HBX9 1/20 0.49
▸ SIGMAR1 Q99720 3/20 0.47
▸ HTR2B P41595 3/20 0.47
▸ ADRA2C P18825 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2784929 1.00 HIF1A (0.75) HIF1ATP53STAT6PAX8ADK
SCHEMBL2784937 1.00 HIF1A (0.75) HIF1ATP53STAT6PAX8ADK
SCHEMBL13021323 0.87 HIF1A (0.57) HIF1ATP53STAT6PAX8
SCHEMBL2788440 0.87 HIF1A (0.77) HIF1ATP53STAT6PAX8ADK
SCHEMBL2788446 0.87 HIF1A (0.77) HIF1ATP53STAT6PAX8ADK
SCHEMBL3658127 0.86 HIF1A (1.00) HIF1ATP53STAT6PAX8ADK
SCHEMBL3658125 0.86 HIF1A (1.00) HIF1ATP53STAT6PAX8ADK
Hydrochloric Acid SCHEMBL2386489 0.85 HIF1A (0.98) HIF1ATP53STAT6PAX8ADK
SCHEMBL2786328 0.85 HIF1A (0.74) HIF1ATP53STAT6PAX8ADK
SCHEMBL2786320 0.85 HIF1A (0.74) HIF1ATP53STAT6PAX8ADK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100297079-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTION CHIMERIX, INC. (US) 2010-11-25 — — US disclosed
US-20100297079-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTION CHIMERIX, INC. (US) 2010-11-25 — — US disclosed
WO-2010135520-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTION CHIMERIX, INC. (US) 2010-11-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100297079-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTION HAVCR2, EIF2AK2, OAT HIF1A 247/4885TP53 2531/4885STAT6 1884/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback